Cancer Causes & Control

, Volume 22, Issue 7, pp 1055–1059

Commentary: Serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial

Authors

    • Departments of Nutrition and EpidemiologyHarvard School of Public Health
    • Department of MedicineChanning Laboratory, Brigham and Women’s Hospital and Harvard Medical School
Brief report

DOI: 10.1007/s10552-011-9776-x

Cite this article as:
Giovannucci, E. Cancer Causes Control (2011) 22: 1055. doi:10.1007/s10552-011-9776-x

Abstract

A recent analysis in the Prostate Cancer Prevention Trial (PCPT) appeared to show no association between serum lycopene and prostate cancer risk, but the unique study design of the PCPT and the complexity of prostate cancer epidemiology suggest an alternative interpretation of the reported findings.

Keywords

Prostate cancerLycopenePSA screening

Copyright information

© Springer Science+Business Media B.V. 2011